Chris Meyer

Chris Meyer's work experience includes various roles in strategic planning, operations, and finance.

From 2022 onwards, Chris has been serving as the Operations Product Lead Director at Atara Biotherapeutics. Prior to that, from 2021 to 2022, they worked as the Director of Strategic Planning at the same company.

Before joining Atara Biotherapeutics, Chris worked at Kite Pharma from 2018 to 2021. During this time, they held the positions of Director of Corporate Strategic Planning and Director of Operations Strategic Planning.

From 2016 to 2018, Chris worked at Shire as the Network and Capacity Planning Lead, responsible for long-range network capacity and demand planning for the company's plasma proteins manufacturing network.

Prior to that, Chris held the role of Director of Operations Strategy at Baxalta from 2015 to 2016.

From 2005 to 2015, Chris held various roles at Baxter International Inc., including Director of Operations Strategy, Director of Operations Planning, and Director of Operational Excellence.

In 2004, Chris worked as a Senior Finance Manager at Amgen.

Before that, from 1995 to 2004, they worked at Baxter International Inc. in roles such as Plant Controller and Supervisor of Corporate Staff.

Chris began their career at Essendant in 1989, where they worked as a Senior Budget Analyst and Senior Internal Auditor.

In 1987, they started their career as a Public Accountant and Auditor at Arthur Andersen.

Chris Meyer obtained a Bachelor of Arts in Accounting and Finance from Indiana University Bloomington from 1983 to 1987. Chris also holds a certification as a Certified Public Accountant from the Illinois CPA Society, obtained in 1991.